Health Care Equipment & Services

Carlsmed, Inc. secures its S‑3 registration, boosting its AI‑driven spine‑surgery platform and market position in the U.S. healthcare sector.

Abbott Laboratories’ $117 stock outpaces its $94 DCF value—why med‑tech momentum may be inflating prices and how investors can spot overvaluation in 2026.

Explore how Sunnyvale-based EBR Systems is pioneering wireless cardiac pacing amid market volatility, and why its tech could reshape heart care.

Intuitive Surgical’s recent executive stock sales spark investor curiosity as the company’s share price fluctuates and calls for more transparency amid a competitive medical‑equipment market.

Dexcom files Form 144 to sell 26,700 shares, revealing insider activity and highlighting its leading continuous glucose monitoring technology.

Explore Clover Health’s Q2 earnings report, AI‑driven care coordination, and expansion plans that boost Medicare Advantage outcomes and shareholder value.

Hedera Group AB’s niche healthcare recruitment thrives amid stock volatility—discover how the Stockholm‑based firm tackles market swings and growth.

Discover why DorsaVi, the Australian biotech firm behind wireless injury‑monitoring sensors, faces steep financial challenges and how its tech could still reshape healthcare.

Boston Scientific’s $50.37 stock rebound shows robust growth, driven by its cutting‑edge medical device portfolio and strong 20.41 PE ratio.

UnitedHealth Group faces IRS scrutiny, a modest dividend, and split valuation views—investors weigh the firm’s financial strength amid regulatory pressure and upcoming securities sale.